The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Fatigue and AnemiaFatigue and Anemia
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Apr 8, 2008

Dear Doctor, My name is Walter, brazilian, HIV positive since 1999. I had pneumonia, sinusites diharreia, but my infectologist no decide to start the haart therapy. My last exam showed 800 CD4 36.000 viral load, but my CD4 was low like 480 and 500 and viral load about 126.000. In Brazil, the consense is start with the drugs when CD4 about 300 or 200. Is it correct in your opinion?

My best wishes, Walter

Response from Dr. Frascino

Hello Brazilian Walter,

Many factors come into play when deciding when to begin antiretroviral therapy. You can read about these in the archives. Published guidelines for when to start have been revised several times over the 26-year course of the pandemic as we learned more about HIV pathogenesis and new treatments were developed and became more widely available. Most current published guidelines suggest antiretroviral therapy be started when the CD4 count falls into the 350-cell range. With the availability of newer, novel, more potent, less toxic medications, some HIV specialists are recommending starting at even higher CD4 levels.

Good luck.

Dr. Bob

Risk of HIV and other STDs from the various encounters
Sustiva and fatigue (SUSTIVA AND FATIGUE)

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint